Glaxo’s Promacta Holds Promise – Analyst Blog
Updates related to pipeline and label expansion efforts are eagerly awaited by investors in the biotech pharma space as these …read more
Investing and Market Analysis
Novartis Submits Bexsero to FDA for Marketing Approval – Analyst Blog
Novartis ( NVS ) announced the submission of its Biologic License Application (BLA) for meningitis B vaccine candidate Bexsero to …read more
Vertex Pharmaceuticals Crumbles on Analyst Worries – Analyst Blog
Bernstein analyst Geoff Porges has concluded that two pivotal phase III studies (TRAFFIC and TRANSPORT) on Vertex Pharmaceuticals Incorporated ‘s …read more
Amazon Appstore Apps Triple to 240,000 – Analyst Blog
Ahead of the rumored release of its 3D smartphone on Jun 18 in Seattle, giant online retailer Amazon.com Inc. ( …read more
Trina Solar Modules for Solar Project in China – Analyst Blog
Solar module manufacturer Trina Solar Limited ( TSL ) will supply 23 MW of photovoltaic (“PV”) modules to Linuo Solar …read more
Balanced View on Robert Half – Analyst Blog
On Jun 13, 2014, we issued an updated research report on Robert Half International Inc ( RHI ). This global …read more
Gilead’s HCV Combination Therapy Data Looks Promising – Analyst Blog
Gilead Sciences ( GILD ) announced encouraging top line results from a phase III study (GS US 337 0113 n=341) …read more
NRG Energy Launches 6-MW Community Solar Facility – Analyst Blog
NRG Energy, Inc. ( NRG ) announced that it has launched the NRG Community 1 Solar Generating Facility in California. …read more
Six Reasons to Buy Nike Stock for Long Term Gains – Analyst Blog
by Thomas Young In a couple of weeks, Nike, Inc. ( NKE ) will release earnings (June 26). Regardless of …read more
Weighing The Week Ahead: What Does The Iraq Conflict Mean For Markets?
By Jeff Miller Into the economic news vacuum, summer doldrums, and sports stories, there was finally some real news the …read more